Free Account Opening + AMC Free Demat
Loading...
April 25, 2023 - April 27, 2023

Mankind Pharma IPO Subscription Details

Mankind Pharma IPO Subscription Status Live

Mankind Pharma IPO subscribed 15.32 times. The public issue subscribed 0.92 times in the retail category, 49.16 times in QIB, and 3.80 times in the NII category by April 27, 2023 (Day 3).

Investor CategorySubscription (times)Shares OfferedShares Bid forTotal Amount (Rs Cr.)*
Qualified Institutions49.168,011,76939,38,34,10342,534.08
Non-Institutional Buyers3.806,008,8272,28,22,7612,464.86
  bNII (bids above ₹10L)4.994,005,8852,00,00,5002,160.05
  sNII (bids below ₹10L)1.412,002,94228,22,261304.80
Retail Investors0.9214,020,5961,28,56,0381,388.45
Employees[.]000
Others[.]000
Total 15.3228,041,19242,95,12,90246,387.39

Total Application : 462,789 (0.43 times)

Disclaimer: *The total amount is calculated based on the final issue price or the price in the upper price range.


Mankind Pharma IPO (Day-wise) Subscription Details (times)

DateQIBNIIRetailTotal
Day 1
April 25, 2023
0.080.330.110.15
Day 2
April 26, 2023
1.861.020.250.88
Day 3
April 27, 2023
49.163.800.9215.32

Mankind Pharma IPO Shares Offered

Mankind Pharma IPO is a public issue of 40,058,844 equity shares. The issue offers 14,020,596 shares to retail investors, 8,011,769 shares to qualified institutional buyers, and 6,008,827 shares to non-institutional investors.

CategoryShares OfferedAmount (Rs Cr) Size (%)
Anchor Investor12,017,6521,297.9130.00%
QIB8,011,769865.2720.00%
NII6,008,827648.9515.00%
    bNII (bids above ₹10L)4,005,885432.6410.00%
    sNII (bids below ₹10L)2,002,942216.325.00%
Retail14,020,5961,514.2235.00%
Total40,058,8444,326.36100%

IPO Investor Categories

  • Qualified Institutional Buyers (QIB)

    Financial Institutions, Banks, FIIs, and Mutual Funds registered with SEBI are called QIBs. In most cases, QIBs represent small investors who invest through mutual funds, ULIP schemes of insurance companies, and pension schemes.

  • Non-Institutional Investors(NII)

    Retail Individual Investors (HNI), NRIs, Companies, Trusts, etc who bid for shares worth more than Rs 2 lakhs are known as Non-institutional bidders (NII). Unlike QIB bidders, they do not need SEBI registration.

    NII category has two subcategories:

    1. sNII (bids below Rs 10L)

      The Small NII category is for NII investors who bid for shares between Rs 2 lakhs to Rs 10 lakhs. The 1/3 of NII category shares are reserved for the Small NII sub-category. This subcategory is also known as Small HNI (sHNI).

    2. bNII (bids above Rs 10L)

      The Big NII category is for NII investors who bid for shares worth more than Rs 10 Lakhs. The 2/3 of NII category shares are reserved for the Big NII subcategory. This subcategory is also known as Big HNI (bHNI).

  • Retail Individual Investors(RII)

    The retail individual investor or NRIs who apply up to Rs 2 lakhs in an IPO are considered as RII reserved category.

  • Employee (EMP)

    A category of eligible employees who have a reserved quota in the IPO.

  • Others

    A category of eligible shareholders or other investors who have a reserved quota in the IPO.

What is the difference between RII, NII, QIB and Anchor Investor?

Disclaimer: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites. The information / data provided here in is for informational purposes only and is provided by Chittorgarh.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. Chittorgarh.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites. Chittorgarh.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. Chittorgarh.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites. The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.

Mankind Pharma IPO Subscription FAQs

The Mankind Pharma IPO is subscribed 15.32 by April 27, 2023.

Mankind Pharma IPO Subscription

Investor CategorySubscription (times)
Qualified Institutional49.16
Non Institutional3.80
Retail Individual0.92
Employee Reservations[.]
Others[.]
Total Subscription15.32

Retail category of Mankind Pharma IPO subscribed 0.92 times as of date April 27, 2023. The public issue closes on April 27, 2023 for bidding.

An investor can apply in Mankind Pharma IPO online via bank (using ASBA) or the broker (using UPI). The Mankind Pharma IPO shares are offered online only.

The Mankind Pharma IPO is subscribed 15.32 by April 27, 2023.

The Mankind Pharma IPO allotment status is expected on or around May 3, 2023. Visit Mankind Pharma IPO allotment status to check.

The Mankind Pharma IPO listing date is Tuesday, May 9, 2023. The equity share of Mankind Pharma Limited will list on BSE, NSE.

Visit Mankind Pharma IPO subscription status page for real-time bidding information about Mankind Pharma IPO.

Mankind Pharma IPO Timetable

IPO Opens OnApril 25, 2023
IPO Closes OnApril 27, 2023
Finalisation of Basis of AllotmentMay 3, 2023
Initiation of RefundsMay 4, 2023
Credit of Shares to Demat AccountMay 5, 2023
IPO Listing DateMay 9, 2023

2 Comments

2. Trump.in     Link|April 27, 2023 12:08:08 PM
FFI now 5 times .. apply fully, retailers do not trap its a gem company.. mark my words.
2.1. The Honest Retailer.     Link|April 27, 2023 1:00:34 PM
No doubt it's good company but valuation bhi koi cheez hoti hai na bhai. for big player valuation premium mai ho to bhi chal jata Pr retailer need some what discount or atleast 10 % gain at leasting.
1. Lalit     Link|April 25, 2023 5:45:12 PM
Should applied